Literature DB >> 24041830

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.

Agnieszka Baranowska-Bik1, Jan Kochanowski, Dorota Uchman, Ewa Wolinska-Witort, Malgorzata Kalisz, Lidia Martynska, Boguslawa Baranowska, Wojciech Bik.   

Abstract

Multiple sclerosis (MS) is a chronic neuroinflammatory disease of the central nervous system that leads to demyelination and neurodegeneration. VIP and PACAP are structurally related neuropeptides with neuroprotective and anti-inflammatory activities. To evaluate VIP and PACAP-38 in plasma and CSF in humans in correlation with IL-6, IL-10 and TNFα, we compared 20 MS individuals with 27 healthy controls. In MS, a decrease in PACAP-38 in CSF and a decrease in plasma IL-6 concentration were seen. A positive correlation between plasma VIP and plasma IL-6 was identified. We conclude that VIP and PACAP may influence the course of MS.
© 2013.

Entities:  

Keywords:  IL-10; IL-6; Multiple sclerosis; PACAP; TNFα; VIP

Mesh:

Substances:

Year:  2013        PMID: 24041830     DOI: 10.1016/j.jneuroim.2013.08.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer Patients

Authors:  Zeinab K Hassan; Mohamed M Hafez; Mahmoud M Kamel; Abdel Rahman N Zekri
Journal:  Asian Pac J Cancer Prev       Date:  2017-01-01

Review 2.  The Neuroprotective and Biomarker Potential of PACAP in Human Traumatic Brain Injury.

Authors:  Denes Toth; Andrea Tamas; Dora Reglodi
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

3.  Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson's disease focusing on correlations with motor symptoms.

Authors:  Daniel Pham; Beata Polgar; Tunde Toth; Adel Jungling; Norbert Kovacs; Istvan Balas; Endre Pal; Dora Szabo; Balazs Daniel Fulop; Dora Reglodi; Zalan Szanto; Robert Herczeg; Attila Gyenesei; Andrea Tamas
Journal:  Geroscience       Date:  2022-02-26       Impact factor: 7.581

Review 4.  Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.

Authors:  Viktoria Denes; Peter Geck; Adrienn Mester; Robert Gabriel
Journal:  J Clin Med       Date:  2019-09-18       Impact factor: 4.241

Review 5.  A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.

Authors:  Carmen Martínez; Yasmina Juarranz; Irene Gutiérrez-Cañas; Mar Carrión; Selene Pérez-García; Raúl Villanueva-Romero; David Castro; Amalia Lamana; Mario Mellado; Isidoro González-Álvaro; Rosa P Gomariz
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.